iBio, Inc. (NYSEMKT:IBIO)

CAPS Rating: 2 out of 5

A bio-pharmaceutical company focused on the development and commercialization of novel plant-made products for the prevention and treatment of serious infectious diseases.

Recs

0
Player Avatar pchop123 (76.53) Submitted: 7/17/2012 6:44:05 PM : Underperform Start Price: $0.95 IBIO Score: -35.87

Falling back to reality after a nice surge, especially since they could be burning through their cash at to fast a rate without any great success

Featured Broker Partners


Advertisement